Alzheimer's drug shows promise for patients in phase III trial

In what has been hailed "a significant event in the history of Alzheimer's and dementia research," scientists have completed the first ever phase III clinical trial of a drug that targets one of the drivers of Alzheimer's disease - a protein known as tau. More...